ArticleClinical neuropsychiatry2025
ADHD and Suicide Risk: The Overlooked Roles of Comorbid Disorders and Stimulant Medications.
Article in Clinical neuropsychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Does Attention Deficit Hyperactivity Disorder (ADHD) increase the risk of suicidality among children? This article critically examines a notable study by Shahnovsky et al. (2024), which identifies hyperactivity as a significant predictor of suicide attempts. A detailed analysis of the study reveals three critical gaps: (1) oversight of key risk factors, such as ADHD medications and comorbid disorders - some of which were examined in a related study by the same authors, showing no significant association between ADHD and suicidality; (2) misinterpretation of prior research, inaccurately presenting ADHD medications as protective despite evidence indicating a significantly elevated suicide risk among users; and (3) misrepresentation of the study's findings, which largely suggested that ADHD was unrelated to suicide risk based on both parent and child reports and the two examined components of ADHD. Drawing on an extensive body of research, it is argued that depressive symptoms and suicidal ideation are more likely attributable to the first-line treatments for ADHD than to the diagnosis itself. By situating the study within the broader literature, this article cautions against potential real-life implications arising from its conclusions, such as clinicians prescribing ADHD medications to suppress the allegedly dangerous hyperactivity - medications that may paradoxically increase the risk of suicide. This critique is offered with the utmost respect for the authors' lifelong dedication to advancing suicide prevention, with the sincere aim of fostering a constructive dialogue to deepen our understanding of the tragic phenomenon of childhood suicide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.